Home - Products - Others - Other Targets - Thalidomide-O-amido-C3-NH2 TFA

Thalidomide-O-amido-C3-NH2 TFA

CAS No. 2022182-58-5

Thalidomide-O-amido-C3-NH2 TFA( Cereblon Ligand-Linker Conjugates 16 TFA | E3 Ligase Ligand-Linker Conjugates 52 TFA )

Catalog No. M28569 CAS No. 2022182-58-5

Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 42 In Stock
10MG 72 In Stock
25MG 131 In Stock
50MG 222 In Stock
100MG 331 In Stock
200MG 489 In Stock
500MG 777 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Thalidomide-O-amido-C3-NH2 TFA
  • Note
    Research use only, not for human use.
  • Brief Description
    Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
  • Description
    Thalidomide-O-amido-C3-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Cereblon Ligand-Linker Conjugates 16 TFA | E3 Ligase Ligand-Linker Conjugates 52 TFA
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    platelet-activating factor (PAF)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2022182-58-5
  • Formula Weight
    502.403
  • Molecular Formula
    C20H21F3N4O8
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (248.81 mM)
  • SMILES
    OC(=O)C(F)(F)F.NCCCNC(=O)COc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Rylander R, et al. Modulation of pulmonary inflammation after endotoxin inhalation with a platelet-activating factor antagonist (48740 RP). Int Arch Allergy Appl Immunol. 1988;86(3):303-7.
molnova catalog
related products
  • Clocapramine dihydro...

    Clocapramine hydrochloride hydrate is an antagonist of the 5-HT2A and D2 receptors.

  • Adecatumumab

    Adecatumumab (MT201) is a whole-person IgG1 monoclonal antibody to human EpCAM. Adecatumumab has potential anticancer activity and can be used to study breast cancer.

  • Maltotriose

    Maltotriose is a common oligosaccharide metabolite found in human urine after maltose ingestion or infusion. Maltotriose is increased in Glycogen storage disease II due to a mutation of the enzyme alpha-14-glucosidase.